Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Multi-Center Liquid Embolic Study Concludes
10/06/2022
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
Completion of Trial is a Sign of...
10/06/2022
IO Learning

Advertisement

News
Philips announces new milestones in the development of the world’s first spectral detector angio CT solution
09/07/2022
September 7, 2022 Leiden University Medical Center joins global network of partners in the development of Philips Spectral Angio CT suite and its use in clinical research, bringing spectral CT imaging technology into an integrated...
September 7, 2022 Leiden University Medical Center joins global network of partners in the development of Philips Spectral Angio CT suite and its use in clinical research, bringing spectral CT imaging technology into an integrated...
September 7, 2022 Leiden...
09/07/2022
IO Learning
News
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient
09/01/2022
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications
GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications
GPX® Trial Completes Enrollment...
09/01/2022
IO Learning
News
Boston Scientific Announces Acquisition of Obsidio, Inc.
08/16/2022
Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio
Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio
Company to add novel technology...
08/16/2022
Cath Lab Digest

Advertisement

News
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
08/10/2022
Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses
Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses
Fluidx Medical’s GPX Embolic...
08/10/2022
IO Learning
News
Scientists Identify Novel Molecular Biomarkers in Cells That Spread a Deadly Form of Breast Cancer
08/08/2022
Johns Hopkins Medicine  Studying a deadly type of breast cancer called triple negative, Johns Hopkins Medicine scientists say they have identified key molecular differences between cancer cells that cling to an initial tumor and those...
Johns Hopkins Medicine  Studying a deadly type of breast cancer called triple negative, Johns Hopkins Medicine scientists say they have identified key molecular differences between cancer cells that cling to an initial tumor and those...
Johns Hopkins...
08/08/2022
IO Learning
News
New recommendations aim to ease patient access to lung cancer clinical trials
08/05/2022
A new approach to determining admission could boost enrollment numbers and diversity.
A new approach to determining admission could boost enrollment numbers and diversity.
A new approach to determining...
08/05/2022
IO Learning

Advertisement

News
New technology aims toward earlier detection of hepatocellular carcinoma
08/04/2022
University of California, Los Angeles (UCLA), Health Sciences Primary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the United States each year. The high mortality rates can be...
University of California, Los Angeles (UCLA), Health Sciences Primary liver cancer, the third-leading cause of cancer-related death worldwide, takes more than 30,000 lives in the United States each year. The high mortality rates can be...
University of California, Los...
08/04/2022
IO Learning
News
Siemens Healthineers Announces FDA Clearance of ARTIS icono Ceiling Angiography System
08/01/2022
New ceiling-mounted C-arm technology provides excellent image guidance for routine and advanced IR and cardiovascular procedures
New ceiling-mounted C-arm technology provides excellent image guidance for routine and advanced IR and cardiovascular procedures
New ceiling-mounted C-arm...
08/01/2022
Cath Lab Digest
News
Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
07/26/2022
BEDFORD, Mass., July 26, 2022 /PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two publications that evaluated the...
BEDFORD, Mass., July 26, 2022 /PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two publications that evaluated the...
BEDFORD, Mass., July 26,...
07/26/2022
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use